Suppr超能文献

吞咽困难 - ARTSCAN 试验亚组中对吸入的多变量预测模型的结果。

Dysphagia - Results from multivariable predictive modelling on aspiration from a subset of the ARTSCAN trial.

机构信息

Department of Radiation Sciences, Oncology, Umeå University Hospital, Umeå University, Sweden.

Department of Oncology and Radiation Physics, Skåne University Hospital, Lund University, Sweden.

出版信息

Radiother Oncol. 2017 Feb;122(2):192-199. doi: 10.1016/j.radonc.2016.09.001. Epub 2016 Sep 27.

Abstract

PURPOSE

To establish predictive models for late objective aspiration and late patient-reported choking based on dose-volume parameters and baseline patient and treatment characteristics, for patients with head and neck cancer undergoing definitive radiotherapy (RT). The impact of electively treated volume on late aspiration was also investigated.

METHODS AND MATERIAL

This prospective cohort is a subsample of 124 survivors from the ARTSCAN study. Late aspiration was identified with videofluoroscopy, at a minimum of 25months after the start of RT. Patient-reported choking was analysed at 12 and 60months post RT using the EORTC Quality of Life Module for Head and Neck Cancer 35. Univariable and multivariable analyses were performed to describe the association between clinical factors and dose-volume descriptors for organs at risk (OARs) and late dysphagia.

RESULTS

Aspiration was found in 47% of the eligible patients. Mean dose to the middle pharyngeal constrictor (MPC), neck dissection post RT and age at randomisation in ARTSCAN were associated to late aspiration. Mean dose to the superior pharyngeal constrictor (SPC) and swallowing complaints at baseline were associated to patient reported choking at both time-points.

CONCLUSIONS

Three separate risk groups for late aspiration, and two risk groups for late patient-reported choking were identified based on number of risk factors. The size of the electively treated volume could be used as a surrogate for individual OARs predicting late aspiration.

摘要

目的

基于剂量-体积参数以及基线患者和治疗特征,为接受根治性放疗(RT)的头颈部癌症患者建立预测迟发性客观误吸和迟发性患者报告的哽噎的模型。还研究了选择性治疗体积对迟发性误吸的影响。

方法和材料

本前瞻性队列是 ARTSCAN 研究的 124 名幸存者的亚组。在 RT 开始后至少 25 个月,通过视频透视法确定迟发性误吸。在 RT 后 12 个月和 60 个月,使用 EORTC 头颈部癌症 35 生活质量模块分析患者报告的哽噎。使用单变量和多变量分析描述与风险器官(OAR)的剂量-体积描述符和迟发性吞咽困难相关的临床因素之间的关联。

结果

在符合条件的患者中,有 47%的患者发现有误吸。ARTSCAN 中的中咽缩肌(MPC)的平均剂量、RT 后颈部清扫术和随机分组时的年龄与迟发性误吸相关。SPC 的平均剂量和基线时的吞咽困难与两个时间点的患者报告的哽噎相关。

结论

基于危险因素的数量,确定了三个迟发性误吸的独立风险组和两个迟发性患者报告的哽噎的风险组。选择性治疗体积的大小可作为预测迟发性误吸的个体 OAR 的替代指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验